A vaccine made from a person's own cells, added to other glioblastoma treatment
Original title: Evaluate the Efficacy and Safety of ADCV01 as an Add-On Treatment for Primary Glioblastoma Multiforme (GBM) Patients
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is a middle stage test in people, so we do not know yet if it helps.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This trial tests a vaccine made from a person's own cells for a brain tumor.
Who this trial is for. This trial is for people with primary glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary, a type of brain tumor. It tests a vaccine called ADCV01, given along with their other treatment.
Where it stands. The trial has not reported results. It is looking at how well the vaccine works and how safe it is. That answer is not in yet.
What this means, and what it doesn't
What it could mean: This vaccine is still being tested. It is not care your own doctor can give you. If it sounds like a fit, you could ask your care team about it.
What it doesn't mean: A trial is a test, not a proven treatment. Being in one does not mean you will be helped. It is not a promise of a cure.
Source: ClinicalTrials.gov, September 24, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.